文献速递慢阻肺

经鼻高流量氧疗对COPD急性加重期患者二氧化碳分压的生理效应:随机对照交叉试验

Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: A randomized controlled cross-over trial.
PubMed 文献 · Respirology · 2017-05-04

该单中心随机对照交叉试验纳入24例因COPD急性加重住院且经标准鼻导管吸氧的患者,比较经鼻高流量氧疗(35 L/min)与标准鼻导管各30分钟对经皮二氧化碳分压(PtCO2)的影响。结果显示,调整时间零点后,NHF组30分钟PtCO2较SNP组低1.4 mm Hg(95%CI:-2.2至-0.6,P=0.001),SpO2无差异,呼吸频率下降无统计学意义。短期NHF可小幅降低PtCO2,但临床意义不确定。

要点

  • COPD急性加重住院患者短期使用NHF(35 L/min)较标准鼻导管可小幅降低PtCO2。
  • NHF与标准鼻导管在维持SpO2方面无差异。
  • NHF对呼吸频率的降低未达统计学显著性,临床意义尚不确定。

核心结论

  • 在COPD急性加重住院患者中,短期使用经鼻高流量氧疗较标准鼻导管可小幅降低经皮二氧化碳分压,但其临床意义尚不确定。

研究设计与样本

  • 单中心随机对照交叉试验,纳入24例因COPD急性加重住院且经标准鼻导管吸氧的患者。
  • 患者随机顺序接受NHF(35 L/min)和SNP各30分钟,氧流量滴定维持基线SpO2,干预间至少15分钟洗脱期。
  • 主要结局为调整时间零点后30分钟时经皮二氧化碳分压(PtCO2)的差异。

主要发现

  • 调整时间零点后,NHF组30分钟PtCO2较SNP组低1.4 mm Hg(95%CI:-2.2至-0.6,P=0.001)。
  • 30分钟时SpO2组间差异为-0.02%(95%CI:-0.8至0.7,P=0.96)。
  • NHF组30分钟呼吸频率下降2.0次/分(95%CI:-4.5至0.4,P=0.099),无统计学显著性。

临床怎么用

  • 对于COPD急性加重住院且需氧疗的患者,可考虑短期使用NHF以小幅降低PtCO2,但需结合临床评估其获益。
  • 使用NHF时应按基线SpO2滴定氧浓度,避免过度氧疗。

局限性

  • 单中心、样本量小(24例),结果外推需谨慎。
  • 干预时间短(30分钟),未评估长期临床结局。
  • PtCO2降低幅度小,临床意义不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Increased arterial carbon dioxide tension (PaCO2 ) is an important complication of acute exacerbations of COPD. The effects of nasal high-flow cannulae (NHF) on PaCO2 in patients with COPD exacerbations, and whether this therapy should be used in this clinical situation, are less certain. We aimed to investigate the effect of NHF on PaCO2 in patients admitted to hospital with a COPD exacerbation. METHODS: We performed a single-centre randomized controlled cross-over trial in 24 hospital inpatients with acute exacerbations of COPD receiving oxygen via standard nasal prongs (SNPs). Patients received both supplemental oxygen via NHF (35 L/min) and SNP for 30 min each, with oxygen titrated to maintain the patient's baseline oxygen saturation, measured by pulse oximetry (SpO2 ). Interventions were administered in random order with a minimum 15-min washout between interventions. The primary outcome was difference in transcutaneous carbon dioxide tension (PtCO2 ) at 30 min adjusted for time zero. RESULTS: The difference in PtCO2 adjusted for time zero was lower after 30 min for NHF compared with SNP (-1.4 mm Hg (95% CI: -2.2 to -0.6), P = 0.001). There was no difference in SpO2 at 30 min (-0.02% (95% CI: -0.8 to 0.7), P = 0.96). The reduction in respiratory rate for NHF at 30 min was not statistically significant (-2.0 breaths/min (95% CI: -4.5 to 0.4), P = 0.099). CONCLUSION: Short-term use of NHF results in a small reduction in PtCO2 compared with SNP in patients with acute exacerbations of COPD, but whether this is clinically significant is uncertain.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Pilcher J, Eastlake L, Richards M, et al. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: A randomized controlled cross-over trial. Respirology. 2017. PMID: 28470831. doi:10.1111/resp.13050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。